Recent Quotes (30 days)

You have no recent quotes
chg | %

VentriPoint Diagnostics Ltd.  

(Public, CVE:VPT)   Watch this stock  
Find more results for VPT
0.095
0.000 (0.00%)
May 17 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.09 - 0.09
52 week 0.08 - 0.16
Open 0.09
Vol / Avg. 30,050.00/112,383.00
Mkt cap 12.46M
P/E     -
Div/yield     -
EPS -0.03
Shares 131.17M
Beta -1.38
Inst. own     -

Address

Suite 410, 100 West Harrison Street
SEATTLE, WA 98119
United States - Map
+1-206-2830221 (Phone)
+1-206-2832309 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

VentriPoint Diagnostics Ltd. is a Canada-based company. The Company�s wholly owned subsidiary is VentriPoint, Inc. VentriPoint is a medical device company engaged in the development and commercialization of its diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the VentriPoint Medical System (VMS) generates heart measurements and a three-dimensional (3D) model. VentriPoint�s solution produces critical heart information by processing standard information received from existing medical imaging equipment with its methods incorporating algorithms and the VentriPoint Knowledge Based Reconstruction (KBR) database. The Company�s KBR method allows for the creation of a three-dimensional model of the right and/or left ventricle using images generated from existing two dimensional (2D) (or 3D) imaging equipment.

Officers and directors

Treuman P. Katz Independent Chairman of the Board
George Adams President, Chief Executive Officer, Director
Ellen Briant Chief Financial Officer, Corporate Secretary
Don C. Black Independent Director
Hugh Cleland Independent Director
Danny Dalla-Longa Independent Director
Bradley Raines Harlow Independent Director